[The treatment of dermatomyositis].
D000293:Adolescent; D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D000510:Alpha-Globulins / Q000032:analysis; D000974:Antibodies, Antinuclear / Q000032:analysis; D000963:Antimetabolites / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use; D001797:Blood Protein Electrophoresis; D002114:Calcinosis / Q000209:etiology; D002648:Child; D003401:Creatine / Q000652:urine; D003882:Dermatomyositis / Q000188:drug therapy*; D004576:Electromyography; D005081:Exercise Therapy; D005260:Female; D005455:Fluorescent Antibody Technique; D005634:Fructose-Bisphosphate Aldolase / Q000378:metabolism; D006130:Growth Disorders / Q000209:etiology; D006801:Humans; D007165:Immunosuppression Therapy; D007770:L-Lactate Dehydrogenase / Q000378:metabolism; D008297:Male; D015122:Mercaptopurine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D009132:Muscles / Q000201:enzymology; D011241:Prednisone / Q000009:adverse effects / Q000627:therapeutic use; D012075:Remission, Spontaneous; D013203:Staphylococcal Infections / Q000209:etiology; D000637:Transaminases / Q000378:metabolism
D000510:Alpha-Globulins; D000974:Antibodies, Antinuclear; D000963:Antimetabolites; D000324:Adrenocorticotropic Hormone; D015122:Mercaptopurine; D007770:L-Lactate Dehydrogenase; D000637:Transaminases; D005634:Fructose-Bisphosphate Aldolase; D001379:Azathioprine; D003401:Creatine; D011241:Prednisone; D008727:Methotrexate
Le traitement de la dermatomyosite